Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase I study of MPC-6827 in combination with carboplatin for recurrent glioblastoma

		Phase:		Phase 1

		Treatment ID#:		1891 2007-0286

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed recurrent glioblastoma

		Last Updated:		10/27/2008

		Tumor Types:		Glioblastoma Multiforme


		Comments:		MPC-6827 inhibits microtubule assembly, interfering with cell cycle transition and inhibiting cell division. In animal experiments, it has been shown to cross the blood-brain barrier, disrupt blood vessels in tumors and act synergistically with carboplatin.

		Treatment Type:		Chemotherapy

		Contact:		Jan Esenwein Program Coordinator, Brain Tumor Program MD Anderson Cancer Center 1515 Holcombe Blvd Houston, TX 77030- USA Phone: (713)745-2264 Fax: (713)794-4999 E-mail: jesenwei@mdanderson.org Website: www.mdanderson.org/diseases/braincancer/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By